Article info

Download PDFPDF

Correspondence response
Response to: ‘Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?’ by Nocturne et al
Free

Authors

  1. Correspondence to Professor Kimme L Hyrich, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK; kimme.hyrich{at}manchester.ac.uk
View Full Text

Citation

Mercer LK, Galloway JB, Lunt M, et al
Response to: ‘Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?’ by Nocturne et al

Publication history

  • Received October 3, 2016
  • Accepted November 11, 2016
  • First published December 1, 2016.
Online issue publication 
January 10, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.